참고문헌
- Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol 2009;80:1021-32. https://doi.org/10.1902/jop.2009.097001
- Miyajima S, Naruse K, Kobayashi Y, Nakamura N, Nishikawa T, Adachi K, et al. Periodontitis-activated monocytes/macrophages cause aortic inflammation. Sci Rep 2014;4:5171. https://doi.org/10.1038/srep05171
- van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005;5:318-30. https://doi.org/10.1038/nri1593
- Rajaiah R, Moudgil KD. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 2009;8:388-93. https://doi.org/10.1016/j.autrev.2008.12.004
- Choi J, Lee SY, Kim K, Choi BK. Identification of immunoreactive epitopes of the Porphyromonas gingivalis heat shock protein in periodontitis and atherosclerosis. J Periodontal Res 2011;46:240-5. https://doi.org/10.1111/j.1600-0765.2010.01339.x
- Jeong E, Kim K, Kim JH, Cha GS, Kim SJ, Kang HS, et al. Porphyromonas gingivalis HSP60 peptides have distinct roles in the development of atherosclerosis. Mol Immunol 2015;63:489-96. https://doi.org/10.1016/j.molimm.2014.10.004
- Hagiwara M, Kurita-Ochiai T, Kobayashi R, Hashizume-Takizawa T, Yamazaki K, Yamamoto M. Sublingual vaccine with GroEL attenuates atherosclerosis. J Dent Res 2014;93:382-7. https://doi.org/10.1177/0022034514523784
- Choi JI, Chung SW, Kang HS, Rhim BY, Park YM, Kim US, et al. Epitope mapping of Porphyromonas gingivalis heat-shock protein and human heat-shock protein in human atherosclerosis. J Dent Res 2004;83:936-40. https://doi.org/10.1177/154405910408301209
- Cai Y, Kurita-Ochiai T, Kobayashi R, Hashizume T, Yamamoto M. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice. J Oral Sci 2013;55:107-14. https://doi.org/10.2334/josnusd.55.107
- Namikoshi J, Otake S, Maeba S, Hayakawa M, Abiko Y, Yamamoto M. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis. Vaccine 2003;22:250-6. https://doi.org/10.1016/S0264-410X(03)00576-0
- Koizumi Y, Kurita-Ochiai T, Oguchi S, Yamamoto M. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice. Infect Immun 2008;76:2958-65. https://doi.org/10.1128/IAI.01572-07
- Kim HJ, Cha GS, Joo JY, Lee J, Kim SJ, Lee J, et al. Targeting the epitope spreader Pep19 by naive human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy. J Periodontal Implant Sci 2017;47:292-311. https://doi.org/10.5051/jpis.2017.47.5.292
- Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002;2:85-95. https://doi.org/10.1038/nri724
- Nieuwenhuizen NE, Kaufmann SH. Next-generation vaccines based on Bacille Calmette-Guerin. Front Immunol 2018;9:121. https://doi.org/10.3389/fimmu.2018.00121
- Kwon EY, Cha GS, Jeong E, Lee JY, Kim SJ, Surh CD, et al. Pep19 drives epitope spreading in periodontitis and periodontitis-associated autoimmune diseases. J Periodontal Res 2016;51:381-94. https://doi.org/10.1111/jre.12318
- Gotsman I, Gupta R, Lichtman AH. The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2493-5. https://doi.org/10.1161/ATVBAHA.107.153064
- Jeong E, Lee JY, Kim SJ, Choi J. Predominant immunoreactivity of Porphyromonas gingivalis heat shock protein in autoimmune diseases. J Periodontal Res 2012;47:811-6. https://doi.org/10.1111/j.1600-0765.2012.01501.x
- Joo JY, Cha GS, Chung J, Lee JY, Kim SJ, Choi J. Peptide 19 of Porphyromonas gingivalis heat shock protein is a potent inducer of low-density lipoprotein oxidation. J Periodontol 2017;88:e58-64. https://doi.org/10.1902/jop.2016.160402
- Kwon EY, Cha GS, Joo JY, Lee JY, Choi J. Robust immunoreactivity of teenager sera against peptide 19 from Porphyromonas gingivalis HSP60. J Periodontal Implant Sci 2017;47:174-81. https://doi.org/10.5051/jpis.2017.47.3.174
- Zhong Y, Tang H, Wang X, Zeng Q, Liu Y, Zhao XI, et al. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis. Clin Exp Immunol 2016;183:452-68. https://doi.org/10.1111/cei.12726
- de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2007;2:e779. https://doi.org/10.1371/journal.pone.0000779
- Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008;127:89-97. https://doi.org/10.1016/j.clim.2008.01.009
- Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Jorns JM, et al. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther 2009;11:R158. https://doi.org/10.1186/ar2838
-
Konkel JE, Zhang D, Zanvit P, Chia C, Zangarle-Murray T, Jin W, et al. Transforming growth factor-
${\beta}$ signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses. Immunity 2017;46:660-74. https://doi.org/10.1016/j.immuni.2017.03.015 - Taleb S, Tedgui A, Mallat Z. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Arterioscler Thromb Vasc Biol 2015;35:258-64. https://doi.org/10.1161/ATVBAHA.114.303567
- Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, Libby P, et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002;106:1708-15. https://doi.org/10.1161/01.CIR.0000029750.99462.30
- Zhong Y, Wang X, Ji Q, Mao X, Tang H, Yi G, et al. CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice. J Clin Immunol 2012;32:1104-17. https://doi.org/10.1007/s10875-012-9699-7
- Kitz A, Dominguez-Villar M. Molecular mechanisms underlying Th1-like Treg generation and function. Cell Mol Life Sci 2017;74:4059-75. https://doi.org/10.1007/s00018-017-2569-y
- Bullenkamp J, Dinkla S, Kaski JC, Dumitriu IE. Targeting T cells to treat atherosclerosis: odyssey from bench to bedside. Eur Heart J Cardiovasc Pharmacother 2016;2:194-9. https://doi.org/10.1093/ehjcvp/pvw001
- Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177-80. https://doi.org/10.1038/376177a0
- Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996;98:70-7. https://doi.org/10.1172/JCI118779